SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-020440
Filing Date
2024-03-06
Accepted
2024-03-06 16:21:12
Documents
18
Period of Report
2024-03-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0201235-8k_adialpharma.htm   iXBRL 8-K 40509
2 FORM OF NEW WARRANT ea0201235ex4-1_adialpharma.htm EX-4.1 107644
3 FORM OF PLACEMENT AGENT WARRANT ea0201235ex4-2_adialpharma.htm EX-4.2 99839
4 FORM OF WARRANT INDUCEMENT AGREEMENT BY AND BETWEEN ADIAL PHARMACEUTICALS, INC. ea0201235ex10-1_adialpharma.htm EX-10.1 47999
5 PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON MARCH 1, 2024 ea0201235ex99-1_adialpharma.htm EX-99.1 11485
  Complete submission text file 0001213900-24-020440.txt   557299

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20240301.xsd EX-101.SCH 3024
7 XBRL LABEL FILE adil-20240301_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE adil-20240301_pre.xml EX-101.PRE 22365
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0201235-8k_adialpharma_htm.xml XML 3588
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 24726174
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)